Elizabeth Crowley

1.4k total citations
39 papers, 1.0k citations indexed

About

Elizabeth Crowley is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elizabeth Crowley has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elizabeth Crowley's work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Advanced Radiotherapy Techniques (6 papers). Elizabeth Crowley is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Advanced Radiotherapy Techniques (6 papers). Elizabeth Crowley collaborates with scholars based in United States, Germany and Denmark. Elizabeth Crowley's co-authors include Thomas Hawthorne, Thomas A. Davis, Ronit Simantov, Linda T. Vahdat, Ulrik Lassen, Mansoor N. Saleh, Jennifer Green, Theodore S. Hong, Richard T. Penson and Margo Heath‐Chiozzi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Elizabeth Crowley

39 papers receiving 977 citations

Peers

Elizabeth Crowley
Valérie Panet-Raymond Canada
Amélie Lusque France
Catherine Park United States
Kevin S. Choe United States
Xianxin Qiu China
Markus W. Buechler Germany
Guosheng Feng China
Tatsuya Yoshimasu Japan
Katharina Lückerath Germany
Benjamin J. Frisch United States
Valérie Panet-Raymond Canada
Elizabeth Crowley
Citations per year, relative to Elizabeth Crowley Elizabeth Crowley (= 1×) peers Valérie Panet-Raymond

Countries citing papers authored by Elizabeth Crowley

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Crowley more than expected).

Fields of papers citing papers by Elizabeth Crowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Crowley. The network helps show where Elizabeth Crowley may publish in the future.

Co-authorship network of co-authors of Elizabeth Crowley

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Crowley. A scholar is included among the top collaborators of Elizabeth Crowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Crowley. Elizabeth Crowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maurer, Marcus, Martin Metz, John Anderson, et al.. (2025). Anti‐ KIT Barzolvolimab for Chronic Spontaneous Urticaria. Allergy. 80(8). 2178–2186. 6 indexed citations
2.
Abston, Eric, Iris Y. Zhou, Sergey Shuvaev, et al.. (2023). Noninvasive Quantification of Radiation-Induced Lung Injury Using a Targeted Molecular Imaging Probe. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1228–1239. 3 indexed citations
3.
Maurer, Marcus, Martin Metz, John Anderson, et al.. (2023). Safety and Clinical Activity of Multiple Doses of Barzolvolimab, an anti-KIT Antibody, in Patients with Chronic Spontaneous Urticaria. Journal of Allergy and Clinical Immunology. 151(2). AB133–AB133. 5 indexed citations
4.
Alvarado, Diego, Marcus Maurer, Richard Gedrich, et al.. (2022). Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study. Allergy. 77(8). 2393–2403. 62 indexed citations
5.
Terhorst‐Molawi, Dorothea, Tomasz Hawro, Lea Kiefer, et al.. (2022). Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria. Allergy. 78(5). 1269–1279. 81 indexed citations
6.
7.
Yardley, Denise A., Robert Weaver, Michelle Melisko, et al.. (2015). EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer. Journal of Clinical Oncology. 33(14). 1609–1619. 145 indexed citations
8.
Marron, Thomas U., Adam Binder, Nina Bhardwaj, et al.. (2015). In situ vaccine for low-grade lymphoma: Combination of intratumoral Flt3L and poly-ICLC with low-Dose radiotherapy.. Journal of Clinical Oncology. 33(15_suppl). TPS3105–TPS3105. 3 indexed citations
9.
Mirabeau-Beale, Kristina, Theodore S. Hong, Andrzej Niemierko, et al.. (2014). Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer. Practical Radiation Oncology. 5(3). e113–e118. 42 indexed citations
10.
Marron, Thomas U., Nina Bhardwaj, Elizabeth Crowley, et al.. (2014). Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma. Blood. 124(21). 5473–5473. 3 indexed citations
11.
Dizon, Don S., Lars Damstrup, Neil J. Finkler, et al.. (2012). Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer. International Journal of Gynecological Cancer. 22(6). 979–986. 66 indexed citations
12.
Chen, Ronald C., Harvey J. Mamon, Marek Ancukiewicz, et al.. (2012). Dose–Volume Effects on Patient-Reported Acute Gastrointestinal Symptoms During Chemoradiation Therapy for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 83(4). e513–e517. 20 indexed citations
13.
Wolfgang, John A., et al.. (2011). Motion Management For Proton SBRT Liver Treatment: Use Of Serial 4DCT To Determine Optimal Localization Strategy. International Journal of Radiation Oncology*Biology*Physics. 81(2). S884–S885. 2 indexed citations
14.
Winkfield, Karen M., Andrzej Niemierko, Marc R. Bussière, et al.. (2011). Modeling Intracranial Second Tumor Risk and Estimates of Clinical Toxicity with Various Radiation Therapy Techniques for Patients with Pituitary Adenoma. Technology in Cancer Research & Treatment. 10(3). 243–251. 13 indexed citations
15.
Lassen, Ulrik, L. Rhoda Molife, Laura Vidal, et al.. (2010). A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours. British Journal of Cancer. 103(1). 12–17. 72 indexed citations
16.
Zhu, Xuping, Timothy G. Reese, Elizabeth Crowley, & Georges El Fakhri. (2009). Improved MAGIC gel for higher sensitivity and elemental tissue equivalent 3D dosimetry. Medical Physics. 37(1). 183–188. 20 indexed citations
17.
Molife, R., James Lee, Daniel Petrylak, et al.. (2007). A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors.. Molecular Cancer Therapeutics. 6. 2 indexed citations
18.
Kozak, Kevin R., Lisa A. Kachnic, Judith Adams, et al.. (2007). Dosimetric Feasibility of Hypofractionated Proton Radiotherapy for Neoadjuvant Pancreatic Cancer Treatment. International Journal of Radiation Oncology*Biology*Physics. 68(5). 1557–1566. 35 indexed citations
19.
Kozak, Kevin R., Angela Katz, Judith Adams, et al.. (2006). Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1572–1578. 48 indexed citations
20.
Hong, Theodore S., Elizabeth Crowley, Joseph H. Killoran, & Harvey J. Mamon. (2006). Considerations in Treatment Planning for Esophageal Cancer. Seminars in Radiation Oncology. 17(1). 53–61. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Panet-Raymond Breakdown of academic impact, for papers by Amélie Lusque Breakdown of academic impact, for papers by Catherine Park Breakdown of academic impact, for papers by Kevin S. Choe Breakdown of academic impact, for papers by Xianxin Qiu Breakdown of academic impact, for papers by Markus W. Buechler Breakdown of academic impact, for papers by Guosheng Feng Breakdown of academic impact, for papers by Tatsuya Yoshimasu Breakdown of academic impact, for papers by Katharina Lückerath Breakdown of academic impact, for papers by Benjamin J. Frisch
Rankless by CCL
2026